Որոնման արդյունքները - Kerstin Allen
- Ցուցադրվում են 1 - 7 արդյունքները 7
-
1
a Phase 1 Evaluation of Duvelisib (IPI-145), a PI3K-δ,γ Inhibitor, in Patients with Relapsed/Refractory iNHL Ian W. Flinn, Yasuhiro Oki, Manish R. Patel, Steven M. Horwitz, Francine M. Foss, Jennifer Sweeney, Kerstin Allen, Mark Douglas, Lori Steelman, Joi Dunbar, Howard M. Stern, Patrick Kelly, Brad S. Kahl
Հրապարակվել է 2014Artigo -
2
Ravulizumab in Aquaporin‐4–Positive Neuromyelitis Optica Spectrum Disorder Sean J. Pittock, Michael Barnett, Jeffrey L. Bennett, Achim Berthele, de Sèze, Michael Levy, Ichiro Nakashima, Celia Oreja‐Guevara, Jacqueline Palace, Friedemann Paul, Carlo Pozzilli, Marcus Yountz, Kerstin Allen, Yasmin Mashhoon, Ho Jin Kim
Հրապարակվել է 2023Artigo -
3
Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignancies Ian W. Flinn, Susan O’Brien, Brad S. Kahl, Manish R. Patel, Yasuhiro Oki, Francine F. Foss, Pierluigi Porcu, Jeffrey A. Jones, Jan A. Burger, Nitin Jain, Virginia Kelly, Kerstin Allen, Mark Douglas, Jennifer Sweeney, Patrick Kelly, Steven M. Horwitz
Հրապարակվել է 2017Artigo -
4
Duvelisib, an oral dual PI3K‐δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study Susan O’Brien, Manish R. Patel, Brad S. Kahl, Steven M. Horwitz, Francine M. Foss, Pierluigi Porcu, Jeffrey A. Jones, Jan A. Burger, Nitin Jain, Kerstin Allen, L. Kerrie, Mark Douglas, Howard M. Stern, Jennifer Sweeney, Patrick Kelly, Virginia Kelly, Ian W. Flinn
Հրապարակվել է 2018Artigo -
5
Survival Data and Predictors of Functional Outcome an Average of 15 Years after the Fontan Procedure: The Pediatric Heart Network Fontan Cohort Andrew M. Atz, Victor Zak, Lynn Mahony, Karen Uzark, Peter Shrader, Dianne Gallagher, Stephen M. Paridon, Richard V. Williams, Roger E. Breitbart, Steven D. Colan, Jonathan R. Kaltman, Renée Margossian, Sara K. Pasquali, Kerstin Allen, Wyman W. Lai, Rosalind Korsin, Bradley S. Marino, Nicole Mirarchi, Brian W. McCrindle
Հրապարակվել է 2014Artigo -
6
Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma Steven M. Horwitz, Raphael Koch, Pierluigi Porcu, Yasuhiro Oki, Alison J. Moskowitz, Megan N. Perez, Patricia L. Myskowski, Adam Officer, Jacob D. Jaffe, Sara Morrow, Kerstin Allen, Mark Douglas, Howard M. Stern, Jennifer Sweeney, Patrick Kelly, Virginia Kelly, Jon C. Aster, David T. Weaver, Francine M. Foss, David M. Weinstock
Հրապարակվել է 2017Artigo -
7
Interstage mortality after the Norwood procedure: Results of the multicenter Single Ventricle Reconstruction trial Nancy S. Ghanayem, Kerstin Allen, Sarah Tabbutt, Andrew M. Atz, Martha L. Clabby, David S. Cooper, Pirooz Eghtesady, Peter C. Frommelt, Peter J. Gruber, Kevin D. Hill, Jonathan R. Kaltman, Peter C. Laussen, Alan B. Lewis, Karen J. Lurito, L. LuAnn Minich, Richard G. Ohye, Julie V. Schonbeck, Steven M. Schwartz, Rakesh K. Singh, Caren S. Goldberg
Հրապարակվել է 2012Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Internal medicine
Medicine
Adverse effect
Gastroenterology
Lymphoma
Pharmacodynamics
Pharmacokinetics
Cardiology
Chronic lymphocytic leukemia
Clinical trial
Febrile neutropenia
Heart disease
Immunology
Leukemia
Neutropenia
Oncology
Pediatrics
Phases of clinical research
Alternative medicine
Anemia
Antibody
Astrobiology
Biology
Biotechnology
Cancer research
Chemotherapy
Clinical endpoint
Cmax
Cohort
Complement system